LEXINGTON, Ky. (July 6, 2023) — Charles “Chipper” Griffith III, M.D., has been n...
Leesburg, VA, July 7, 2023—According to an accepted manuscript published in the ...
Ikoma, Japan – Plants have the unique ability to regenerate entirely from a soma...
Credit: Kessler Foundation East Hanover, NJ – July 7, 2023 – June’s job numb...
A study led by Nagoya University in Japan has identified three previously unknow...
Discovering new materials and drugs typically involves a manual, trial-and-error...
“Here we report an unusual association of t (5; 17) with t (8; 21) in AML and we...
UNIVERSITY PARK, Pa. — The ability to regenerate and pattern blood vessels, the ...
Extinct dwarf hippos that once roamed Madagascar lived in forests rather than op...
Amneal Pharmaceuticals were positive about launching their extended-release trea...
Dexmedetomidine is under clinical development by Teikoku Pharma USA and currentl...
Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus...
ABBV-101 is under clinical development by AbbVie and currently in Phase I for Re...
CC-95775 is under clinical development by Bristol-Myers Squibb and currently in ...
MesoCancerVac is under clinical development by Amphera and currently in Phase I ...
AC-0676 is under clinical development by Accutar Biotechnology and currently in ...
